EFM
E Fund Management Portfolio holdings
AUM
$2.1B
This Quarter Return
+12.44%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.31B
AUM Growth
+$1.31B
(+3.9%)
Cap. Flow
-$33.1M
Cap. Flow
% of AUM
-2.52%
Top 10 Holdings %
Top 10 Hldgs %
65.03%
Holding
329
New
20
Increased
146
Reduced
123
Closed
37
Top Buys
| 1 |
KLA
KLAC
|
$9.71M |
| 2 |
Pinduoduo
PDD
|
$8.56M |
| 3 |
iShares Gold Trust
IAU
|
$3.24M |
| 4 |
SPDR Gold MiniShares Trust
GLDM
|
$3.14M |
| 5 |
iShares MSCI Global Gold Miners ETF
RING
|
$3.08M |
Top Sells
| 1 |
Grab
GRAB
|
$40.9M |
| 2 |
NVIDIA
NVDA
|
$7.48M |
| 3 |
Microsoft
MSFT
|
$5.75M |
| 4 |
STAAR Surgical
STAA
|
$4.82M |
| 5 |
Sea Limited
SE
|
$3.38M |
Sector Composition
| 1 | Consumer Discretionary | 45.37% |
| 2 | Technology | 25.37% |
| 3 | Communication Services | 8.93% |
| 4 | Healthcare | 6.43% |
| 5 | Real Estate | 6.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Cytokinetics
CYTK
$5.95B
| $374K | 0.03% |
12,681
+619
| +5% | +$18.3K |
|
177
Natera
NTRA
$23.3B
| $373K | 0.03% |
8,437
-795
| -9% | -$35.1K |
|
178
AstraZeneca
AZN
$248B
| $372K | 0.03% |
5,496
+1,076
| +24% | +$72.8K |
|
179
Novavax
NVAX
$1.23B
| $369K | 0.03% |
50,977
-8,815
| -15% | -$63.8K |
|
180
TG Therapeutics
TGTX
$4.69B
| $368K | 0.03% |
44,010
+27,744
| +171% | +$232K |
|
181
Dynavax Technologies
DVAX
$1.16B
| $362K | 0.03% |
24,484
+1,525
| +7% | +$22.5K |
|
182
Acadia Pharmaceuticals
ACAD
$4.36B
| $360K | 0.03% |
17,288
-780
| -4% | -$16.2K |
|
183
CrowdStrike
CRWD
$104B
| $357K | 0.03% |
2,133
+410
| +24% | +$68.6K |
|
184
Walmart
WMT
$780B
| $356K | 0.03% |
2,227
-116
| -5% | -$18.5K |
|
185
Insmed
INSM
$30.9B
| $355K | 0.03% |
14,048
-5,905
| -30% | -$149K |
|
186
Electronic Arts
EA
$42.9B
| $354K | 0.03% |
2,941
+401
| +16% | +$48.3K |
|
187
TE Connectivity
TEL
$60.4B
| $353K | 0.03% |
2,856
-223
| -7% | -$27.6K |
|
188
Twist Bioscience
TWST
$1.57B
| $353K | 0.03% |
17,410
-4,836
| -22% | -$98.1K |
|
189
Iovance Biotherapeutics
IOVA
$800M
| $350K | 0.03% |
76,850
+20,241
| +36% | +$92.2K |
|
190
Abbott
ABT
$229B
| $347K | 0.03% |
3,586
-240
| -6% | -$23.2K |
|
191
Xcel Energy
XEL
$42.6B
| $347K | 0.03% |
6,065
+903
| +17% | +$51.7K |
|
192
CoStar Group
CSGP
$37.4B
| $345K | 0.03% |
4,492
+669
| +17% | +$51.4K |
|
193
Fastenal
FAST
$56.4B
| $343K | 0.03% |
6,282
+922
| +17% | +$50.3K |
|
194
Coca-Cola
KO
$297B
| $340K | 0.03% |
6,074
-426
| -7% | -$23.8K |
|
195
Madrigal Pharmaceuticals
MDGL
$9.74B
| $340K | 0.03% |
2,327
+644
| +38% | +$94.1K |
|
196
Align Technology
ALGN
$9.92B
| $336K | 0.03% |
1,100
+85
| +8% | +$26K |
|
197
Ultragenyx Pharmaceutical
RARE
$3.08B
| $335K | 0.03% |
9,404
+711
| +8% | +$25.3K |
|
198
Trade Desk
TTD
$26.4B
| $329K | 0.03% |
+4,209
| New | +$329K |
|
199
Revolution Medicines
RVMD
$7.35B
| $323K | 0.02% |
11,655
-5,814
| -33% | -$161K |
|
200
Viking Therapeutics
VKTX
$3.07B
| $319K | 0.02% |
28,777
+10,374
| +56% | +$115K |
|